1. Continuous Medical Education Support for Myanmar GPs

Link Pharmaceuticals organized an academic symposium titled “Current Role of SGLT-2 Inhibitors in Management of Diabetes Mellitus – Reflection 2025” to support the continuous medical education and professional development of Myanmar General Practitioners.

The scientific session was led by Prof. Ko Ko, who shared valuable clinical insights regarding the evolving role of SGLT-2 inhibitors in diabetes management.

2. Strengthening Private Label Manufacturing Partnership in 2025

In 2025, Link Pharmaceuticals strengthened its strategic collaboration with one of Myanmar’s leading pharmaceutical manufacturing plants to support the seamless production and supply of Link Pharma quality products for the Myanmar market.

This partnership reflects the company’s commitment to strengthening healthcare accessibility, ensuring product quality, and supporting the sustainable growth of Myanmar’s pharmaceutical sector.